Ixico Regulatory News (IXI)

9 May 2007 14:40

Phytopharm PLC09 May 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer PHYTOPHARM PLC 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (III) BOTH (I) AND (II) 3. Name of person discharging managerial responsibilities/director DR DARYL REES, CHIEF EXECUTIVE 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person AS 3 ABOVE 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest AS 3 ABOVE 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares ORDINARY SHARES OF 1 PENCE EACH 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them AS 3 ABOVE .................................... 8 State the nature of the transaction SHARES ACQUIRED .................................... 9. Number of shares, debentures or financial instruments relating to sharesacquired 18,989 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0003% 11. Number of shares, debentures or financial instruments relating to sharesdisposed .................................... 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) .................................... 13. Price per share or value of transaction 52.66 PENCE PER SHARE... 14. Date and place of transaction 9 MAY 2007, LONDON... 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 18,989, 0.0003% 16. Date issuer informed of transaction 9 MAY 2007 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant .................................... 18. Period during which or date on which it can be exercised .................................... 19. Total amount paid (if any) for grant of the option .................................... 20. Description of shares or debentures involved (class and number) .................................... .................................... 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise .................................... 22. Total number of shares or debentures over which options held followingnotification .................................... 23. Any additional information .................................... 24. Name of contact and telephone number for queries ZOE MCGOWAN 01480 437697 Name and signature of duly authorised officer of issuer responsible for makingnotification ZOE MCGOWAN Date of notification 9 MAY 2007 END This information is provided by RNS The company news service from the London Stock Exchange